Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Is Chinese Government Killing the Chicken to Scare the Monkeys or for Its Eggs?
Chief Editor James Shen offers his regular monthly review of the Chinese healthcare sector with this month's emphasis on latest government actions, new regulations, indus... (8/25/2014)
   
A Short-Term Conviction Leaves Big Long-Term Questions Unanswered (8/28/2014)
ZS: The Secret to Reducing the Impact of Turnover Is Hidden in Plain Sight (8/27/2014)
ZS: Are You Ready for the Lower Tier Market? (8/27/2014)
Chinese Pharma R&D Marks Step Forward (External) (8/25/2014)
Is Chinese Government Killing the Chicken to Scare the Monkeys or for Its Eggs? (8/25/2014)
Lancet: Challenges of Effective Cancer Control in China (External) (8/15/2014)
Pricing, Marketing and PPoC Hot Topics at CNMA Meeting (8/14/2014)
CNBC: Will Generic Viagra Transform China's ED Market? (8/8/2014)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in Q2/2014 (8/1/2014)
What China's Anti-Corruption Investigation Means For International Business (External) (7/31/2014)
The Next Hotspots for CMO/CRO Growth in China (External) (7/31/2014)
Indegene: Cracking the China Conundrum & "Robo-reps" (7/24/2014)
IBT: After GSK Crisis, China's Anti-Corruption Drive No Damper On Foreign Business Enthusiasm (External) (7/24/2014)
China Mulls New Reform Approaches as Healthcare Expenditure Growth Tamed in 2013 (7/18/2014)
Another Twist in the Ongoing GSK-China Scandal (7/15/2014)
Shanghai Issues New Policy to Promote Lo...  (8/28/2014)
China to Expedite Development of Commerc...  (8/28/2014)
SciClone, BTG Announce Chinese Approval ...  (8/28/2014)
Sanofi Licenses Two Novel Respiratory Dr...  (8/28/2014)
Merck Serono Breaks Ground on Its New Fa...  (8/27/2014)
Upcoming Event: World Class Laboratories...  (8/27/2014) (free)
Upcoming Event: Generics 2014  (8/27/2014) (free)
Upcoming Event: OTC Pharma China  (8/27/2014) (free)
Upcoming Event: Med Device Asia  (8/27/2014) (free)
Publicly-listed Chinese Biopharma Compan...  (8/27/2014)
China Further Liberalizes Foreign Invest...  (8/26/2014)
New Report: China the Second Largest Cli...  (8/26/2014)
Chinese Advertisement Law Amendment to H...  (8/26/2014)
Hanmi Licenses China Rights of Novel Ant...  (8/25/2014)
Review of Chinese Foreign Trade of Bioch...  (8/25/2014)
GSK May Spin Off Its Consumer Healthcare Division
Abbvie to Acquire Shire for US$55 Billion
Survey: Smartphones Preferred Healthcare Communication C...
Shire Rejects Takeover Offer from Abbvie
Merck, Sanofi, Glaxo Move to Unload Older Drugs
Review of Chinese Foreign Trade of Biochemical Drugs in H1/2014...
Sinohealth: China Pharmaceutical Market to Grow 16% in 2014
Nicholas Hall Reports Fresh Data on the Chinese OTC Analgesics ...
Monoclonal Antibody Drugs Saw Sharp Growth in China
Data Snapshot: Hospital Consumption of Oral Diabetes Drugs in S...
Shanghai Issues New Policy to Promote Local Biopharma Indust...
SciClone, BTG Announce Chinese Approval of Novel Liver Cance...
Sanofi Licenses Two Novel Respiratory Drug Candidates to Zai...
Merck Serono Breaks Ground on Its New Facility in Nantong
Publicly-listed Chinese Biopharma Companies Report Impressiv...
CFDA Issues Pharmaceutical Contract Manufacture Regulati...
Review of Drug Registration Applications and Approvals i...
State Council Issues Draft TCM Law for Public Comments
NDRC Proposes to Liberalize Prices of Certain Drug Categ...
CFDA Issues Technical Guidelines for Pharmacokinetics of...
Chinese Advertisement Law Amendment to Heighten Requirements...
CFDA Officials Sued and Accused of Dereliction over Vaccine ...
GSK-linked Investigators Do Not Want to Appeal Their Sentenc...
China Jails GSK-linked Investigators for 2+ Years
GSK-linked Foreign Investigators On Trial in Shanghai
Chinese API Import Volume Grew 15.56% in the First Half
WuXiPharmaTech's API Subsidiary Passed USFDA Inspection
Study: India Heavily Dependent on China for Essential AP...
FDA Issues Warning Letter to Tianjin Zhongan Pharmaceuti...
Snapshot Review of the Chinese Vitamins Industry – Oppo...
Research Team under SIMM Discovers Lead Compound to Pote...
Pfizer Announces China Phase III and IV Results for Lyri...
SIMM Announces Discovery of Two New VEGFR-2 Inhibitor Se...
Six Chinese Pharma Companies Granted Clinical Trial Appr...
GW and PKU Medical Division Receive Grant to Study Commo...
China to Expedite Development of Commercial Health Insur...
China Further Liberalizes Foreign Investment in Medical ...
Mortality of AIDS Drops in China
Sino-France Health Forum Opens
IPSOS Survey Finds Depression A Growing Problem among Ch...
Recent Executive Moves
Allegations Against Former CFDA Commissioner Filed with An...
Another Major Hospital Head under Corruption Investigation...
Recent Executive Moves (Updated)
Recent Executive Moves
Upcoming Event: World Class Laboratories
Upcoming Event: Generics 2014
Upcoming Event: OTC Pharma China
Upcoming Event: Med Device Asia
Upcoming Event: ChinaTrials 7
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
  Pharma China adds one more dis...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links